Every adult who has felt the tingle of a cold sore has met herpes simplex virus 1 at its gentlest, a small blister that fades on its own within a couple of weeks. Yet the same virus lives quietly in the nerves of the face for life, and in rare cases it climbs into the brain, and it has been suspected of playing some part in Alzheimer's disease. Researchers at the Max Delbrück Center and the University Medical Center Hamburg-Eppendorf have now watched it move through lab-grown human skin, layer by layer, and found that it does not spread evenly through the body's tissues. Their work offers a qu
Skin Organoids Map How Herpes Simplex Virus Spreads Between Neighboring Cells
The virus did not treat every skin cell alike.
Mark
Why does it matter that the virus hit different cells differently?
Mimi
It shows infection isn't uniform. Fibroblasts in the dermis carried a lot of virus early, while basal keratinocytes and several hair follicle cell types carried less, even with infected neighbors nearby.
Mark
And the nerves?
Mimi
The virus reached hair follicles and sensory neurons only later. The researchers read that as a sign those cells might have some intrinsic resistance.
Luke
"Might" is doing real work there. The study observed a delay, not a proven resistance mechanism.
Mark
What was new about the method?
Mimi
Spatial transcriptomics. It measures gene activity cell by cell while keeping their position, so they could look at the exact zone where the virus had just arrived.
Mark
What did they see there?
Mimi
Fibroblasts switched on IER3, keratinocytes raised IRF3, and TNF-family molecules were activated in a coordinated pattern.
Luke
Wyler says TNFs may prove a major player in controlling infection. That's a hypothesis. The work maps the activation; it doesn't show TNFs decide the outcome.
Mark
Does this say anything about Alzheimer's?
Luke
Not directly. The source says HSV-1 is being investigated for a role, and this study is about skin spread in organoids.
Mimi
Right, and the organoids lack immune cells and blood vessels, which is what the next models aim to add.
O Pulso
- A common virus that usually stays dormant in facial nerves can, in rare cases, reach the brain and cause life-threatening inflammation.
- Inside layered human skin grown in the lab, the virus strikes some cell types hard and spares others, leaving the battle lines uneven.
- Dermal fibroblasts become early hosts for large viral loads, while basal keratinocytes and hair follicle cells hold the virus back.
- At the advancing edge of infection, cells switch on antiviral and immune-signaling genes, including IER3, IRF3, and TNF-family molecules, in a coordinated response.
- The team's next step is building richer organoids with immune cells and blood vessels, aiming to learn how the body contains the virus before it reaches the nerves.
Every adult who has felt the tingle of a cold sore has met herpes simplex virus 1 at its gentlest, a small blister that fades on its own within a couple of weeks. Yet the same virus lives quietly in the nerves of the face for life, and in rare cases it climbs into the brain, and it has been suspected of playing some part in Alzheimer's disease. Researchers at the Max Delbrück Center and the University Medical Center Hamburg-Eppendorf have now watched it move through lab-grown human skin, layer by layer, and found that it does not spread evenly through the body's tissues. Their work offers a quiet clue about how the body's first defenses meet a virus that has learned to stay.
A cold sore is the version of herpes simplex virus 1 most people know: a blister on the lip that clears within about two weeks. But the virus does far more than blister. It hides in the nerves of the face, usually dormant, and occasionally breaks out in ways that can reach the brain. Scientists have even begun asking whether its lifelong presence contributes to Alzheimer's disease.
To understand how it behaves, researchers at the Max Delbrück Center and the University Medical Center Hamburg-Eppendorf turned to human skin organoids, small layered models grown in the lab that contain epidermal cells, dermal cells, hair follicles, and nerve-like cells. Flat cell cultures can only show one cell type at a time, but these organoids come closer to real skin. Dr. Emanuel Wyler and Dr. Silvia Albertini, who share first authorship, worked with Dr. Manja Czech-Sioli and Dr. Nicole Fischer to trace the infection step by step.
The virus proved selective. Fibroblasts in the dermis carried large loads early on, while basal keratinocytes and several hair follicle cell types carried comparatively little, even when infected cells sat nearby. Hair follicles and sensory neurons were reached only later, hinting at some built-in resistance.
Using spatial transcriptomics, which reads gene activity in individual cells while preserving their place in the tissue, the team examined the leading edge of infection. There, fibroblasts switched on IER3, and keratinocytes raised IRF3, a regulator of antiviral defense. TNF-family signaling molecules, which help activate the immune system, rose in a coordinated pattern. Wyler suspects these may be central to how well the body controls the virus, and Czech-Sioli called the spread from one cell type to the next fascinating to watch.
The organoids still lack immune cells and blood vessels. Adding them could reveal how the body holds HSV-1 in check before it reaches the nerves, why some cells slow the virus while others help it multiply, and how the inflammation it provokes can damage tissue.
A cold sore is the version of herpes simplex virus 1 that most people know: a blister on the lip or face that clears up by itself within about two weeks. Researchers at the Max Delbrück Center and the University Medical Center Hamburg-Eppendorf (UKE) have now followed what the same virus does inside layered, lab-grown human skin, and their findings were published in Science Advances.
The stakes go beyond cosmetics. HSV-1 infects sensory nerve cells in the face, where it usually stays dormant. In rare cases it reaches the central nervous system and causes life-threatening brain inflammation. It is also being investigated for a possible role in Alzheimer's disease, since its lifelong presence in the nervous system may eventually damage nerve cells.
Dr. Emanuel Wyler, a scientist in the RNA Biology and Posttranscriptional Regulation lab at the Max Delbrück Center, has long wanted to understand how the virus causes disease. With colleagues at UKE, he traced step by step how HSV-1 moves through the several layers of skin. The UKE team includes Dr. Manja Czech-Sioli, senior author of the paper, Dr. Silvia Albertini, who shares first authorship with Wyler, and Dr. Nicole Fischer. The model was human hair-bearing skin organoids, supplied by the groups of Czech-Sioli and Fischer.
Skin is built like a layered sandwich. The epidermis on the outside consists mainly of keratinocytes. Beneath it lies the dermis, rich in fibroblasts, and hair follicles and sensory nerve fibers run through both. Flat cell cultures can show how a virus behaves in a single cell type, but these organoids contain epidermal cells, dermal cells, hair follicles and nerve-like cells, making them a closer stand-in for real skin.
The virus did not treat all cells alike. Fibroblasts in the dermis carried large amounts of virus early in the infection. Basal keratinocytes in the lower epidermis, and several types of hair follicle cells, carried comparatively little, even with infected cells close by. Hair follicles and sensory neurons were reached only later, which suggests both may have some built-in resistance to the virus.
The team then paired imaging with spatial transcriptomics, a method that measures gene activity in individual cells while keeping track of where they sit in the tissue. That let them examine the leading edge of infection, where the virus had just reached new cells, and see which genes switched on. There, dermal fibroblasts activated IER3, a gene known to respond to HSV-1, and basal keratinocytes increased IRF3, a regulator of antiviral defenses. Members of the tumor necrosis factor (TNF) family of signaling molecules were also activated in a spatially coordinated way.
Wyler said TNFs activate the immune system and may be a major factor in how well the body controls the infection. Czech-Sioli described it as fascinating to watch the virus move from one cell type to another and to see how each responded.
The organoids still lack immune cells and blood vessels. The researchers say future models that include them could help address how the body holds HSV-1 in check before it reaches nerves, why some cells slow the virus while others support its replication, and how infection and the resulting inflammation damage tissue.
Citações Notáveis
TNFs activate the immune system and may prove to be a major player in determining how well our bodies can control the infection.— Dr. Emanuel Wyler, Max Delbrück Center
It was fascinating to see how the virus spreads through the organoid tissue and how each cell type responds.— Dr. Manja Czech-Sioli, UKE (paraphrased)
Quer a matéria completa?
Leia o original em News-Medical ↗
Health & Medicine